Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	40.47	102.66	73.08
Graham Fair Price	-12.20	2.04	2.33
PEG	3679.08	-1.65	0.04
Price/Book	-8.44	1.67	1.82
Price/Cash Flow	-62.49	-94.89	-58.40
Prices/Earnings	41.30	48.44	34.28
Price/Sales	61.29	15.21	9.43
Price/FCF	-62.49	-94.89	-58.40
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.80	0.26	0.27
Operating Margin	28.35	0.11	0.09
ROA	-37.54	< 0.005	< 0.005
ROE	0.01	< 0.005	-35.21
ROIC	0.01	< 0.005	-39.06
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.19	-0.02	695.00
Dividends QOQ	-0.28	0.28	1.94
EBIT QOQ	3.58	-0.28	-92.30
EPS QOQ	7.84	-0.29	-96.26
FCF QOQ	-0.02	0.44	1842.78
Revenue QOQ	0.61	-0.44	-28.00
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	196.68	445.94	126.74
Days Sales Outstanding (DSO)	182.38	246.72	35.28
Inventory Turnover	0.46	0.20	-55.90
Debt/Capitalization	0.18	0.21	15.32
Quick Ratio	1.18	0.86	-27.48
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.26	4.65	9.08
Cash	0.26	0.37	42.94
Capex	-0.14	-0.11	25.91
Free Cash Flow	-0.13	-0.08	38.54
Revenue	0.82	0.51	-38.08
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.03	1.82	-10.21
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.50	10.58	62.92
Naive Interpretation	Member

06 - Financial Health · Weak

Rating